Drug to treat canine lymphoma gets FDA approvalJanuary 3, 2017VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
SPONSORED CONTENTSee what precise nutrition can do.Get to the bottom of tough gastrointestinal cases and recommend diets precisely designed to meet your patients' unique needs. + Find out more
Why clean margins are crucial in feline oral SCCDecember 27, 2016My September column [“Early detection is key with oral cancer”] briefly touched on feline oral squamous cell carcinoma (SCC), but the topic deserves more discussion as a stand-alone column.
Immunotherapy: The next best hope for defeating cancer?December 21, 2016Whether you’re treating something as deadly as cancer or as frustrating as chronic allergies, immunotherapy offers the possibility of slowing or reversing disease.
Collaboration comes together to study cancer in pets and humansNovember 11, 2016Can the study of cancer in dogs lead to new treatment options for humans? Scientists at the North Carolina State University College of Veterinary Medicine and the Duke Cancer Institute believe so and have entered into a collaboration designed to facilitate research projects aimed at benefiting both species.
Early detection is key with oral cancer in small animalsOctober 3, 2016I don’t know whether the incidence of oral tumors in pets is on the rise nationwide, but I do know they comprise more of my caseload than ever before.
NIH issues grant to further canine cancer researchSeptember 30, 2016The National Institutes of Health (NIH) recently awarded a $500,000 grant to fund a study aimed at increasing the understanding about the interactions between cancer and the immune system in dogs with naturally occurring tumors. The researchers will then apply that knowledge to the understanding of human cancer.
How to talk to clients about pet cancerAugust 31, 2016Client communication is an important part of what we do daily as veterinarians. When a cancer diagnosis has been made, this communication can be challenging in many respects due to the emotional shock of diagnosis, preconceived notions about cancer and cancer therapy, and difficulty with end-of-life discussions.
Highlights from the Third World Veterinary Cancer CongressAugust 16, 2016Southern Brazil and nearby Iguazu Falls was the setting in late May for the Third World Veterinary Cancer Congress. The Brazilian, European, Japanese and American cancer societies organized key lectures, which served to nourish the hope, education and collaborative efforts of the 439 attendees representing 27 countries.
How studying cancer in dogs will help humansJuly 11, 2016Using rodent models to study cancer in people hasn’t benefited people much. In recent years, computer studies have furthered knowledge about cancer treatments, but you can’t conduct clinical drug trials on computers.
How Dr. Raelene Wouda is helping fight cancer in animals and humansJune 13, 2016Raelene Wouda, a clinical veterinary oncologist and Kansas State University assistant professor of clinical sciences, is conducting clinical trials to treat cancers in dogs, cats and other companion animals.
